Low cost and high quality. Generics cost an average of 60% less than their brand counterparts. In 2011, the use of lower cost generic prescription medicines saved governments, employers and consumers nearly $8.5 billion. And Mylan applies one global quality standard across our facilities and across our product line... regardless of market.

It’s everyone’s responsibility.

Our worldwide research and development group includes more than 2,600 scientists who innovate every day.

Information on injectables products, as well as for transdermal patches, creams, ointments and sprays.